ROXO 150

Country: Iżrael

Lingwa: Ingliż

Sors: Ministry of Health

Ingredjent attiv:

ROXITHROMYCIN

Disponibbli minn:

UNIPHARM LTD, ISRAEL

Kodiċi ATC:

J01FA06

Għamla farmaċewtika:

TABLETS

Kompożizzjoni:

ROXITHROMYCIN 150 MG

Rotta amministrattiva:

PER OS

Tip ta 'preskrizzjoni:

Required

Manifatturat minn:

TRIMA ISRAEL PHARMACEUTICAL PRODUCTS MAABAROT LTD, ISRAEL

Grupp terapewtiku:

ROXITHROMYCIN

Żona terapewtika:

ROXITHROMYCIN

Indikazzjonijiet terapewtiċi:

For the treatment of infections caused by microorganisms sensitive to roxithromycin e.g: ENT bronchopulmonary, genital and skin manifestations.

Data ta 'l-awtorizzazzjoni:

2011-08-31

Fuljett ta 'informazzjoni

PATIENT PACKAGE INSERT
IN ACCORDANCE WITH THE
PHARMACISTS’ REGULATIONS
(PREPARATIONS) - 1986
This medicine is dispensed with a doctor’s
prescription only.
ROXO 150
Tablets
ACTIVE INGREDIENT:
Each tablet contains:
Roxithromycin 150 mg
Inactive ingredients )see section 6).
Read this leaflet carefully in its entirety
before using the medicine. Keep this leaflet;
you may need to read it again.
This leaflet contains concise information about
the medicine. If you have further questions,
refer to the doctor or pharmacist.
This medicine has been prescribed for you.
Do not pass it on to others. It may harm
them even if it seems to you that their
medical condition is similar.
If a side effect worsens or if a side effect not
mentioned in this leaflet occurs, please refer
to a doctor or pharmacist.
1. WHAT IS THE MEDICINE INTENDED
FOR?
The medicine is intended for the treatment
of infections caused by bacteria susceptible
to roxithromycin, such as infections of the
respiratory tract, including nose, ear and
throat, infections of the skin and genitals.
THERAPEUTIC GROUP: Macrolide antibiotic.
2. BEFORE USING THE MEDICINE DO NOT USE THE MEDICINE:
∙ if there is a known sensitivity to
roxithromycin or to any of the other
ingredients of the medicine, or to another
medicine of the macrolide group )e.g.,
erythromycin).
∙ if you are being concomitantly treated
with ergot derivatives for treatment
of migraine )such as ergotamine and
dihydroergotamine).
∙ if you are being concomitantly treated
with colchicine )to treat gout).
∙ if you are being concomitantly treated
with
medicines
that
can
cause
arrhythmias, such as: cisapride )for
treatment of esophageal reflux), pimozide
)a neuroleptic
medicine
) or medicines
for treatment of allergies containing
terfenadine or astemizole.
∙ when you are breastfeeding and your
baby is being treated with the medicine
cisapride.
SPECIAL WARNINGS REGARDING USE OF THE
MEDICINE: BEFORE TREATMENT WITH ROXO 150, TELL THE
DOCTOR IF:
- you have an intolerance to certain
sugars.
- you are pregna